SAS and Carolina partner to accelerate antiviral drug development

Posted Nov 19, 2021
SAS, a leader in analytics and software services, and the University of North Carolina are teaming up to transform the drug development process to prevent infectious disease threats from turning into a pandemic like COVID-19. The partnership is focused on the work of the University’s Rapidly Emerging Antiviral Drug Development Initiative (READDI). (UNC.edu)

Related: Campus Connections

Eric Church Uses His Guitar To Deliver Powerful Commencement Speech At UNC
UNC-Chapel Hill held its 2026 graduation ceremony, and the commencement address was delivered by North Carolina native and diehard Tar Heel fan Eric Church. And...
Mon May 25, 2026

Carolina Performing Arts Unveils Multi-Day Performance Festival for ‘Campus and Downtown’
May is Mental Health Awareness Month and, in our modern society, many people are struggling with loneliness and finding connection with others. Alison Friedman, the...
Sun May 24, 2026

Play-by-Play Class in UNC’s Journalism School Wraps Up Debut Semester
Listeners of 97.9 The Hill know Matt Krause as the voice of UNC women’s basketball. The most recent season was Krause’s eighth behind the mic...
Sat May 23, 2026

Newly Minted Carolina Alumni Celebrate at Commencement
Country musician and North Carolina native Eric Church delivered the commencement address with his six-string in hand, complemented by a guitar strap featuring an interlocking...
Thu May 21, 2026